Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL

Cyclacel Pharmaceuticals, Inc. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
bcl
relapsed or refractory chronic lymphocytic leukemia, cyc065, cdk2/9, venetoclax, bcl-2, mcl-1, relapsed, refractory, chronic lymphocytic leukemia, small lymphocytic lymphoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 812251
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.